company

PHARMA EASE AS

0375 OSLO

Return on Equity
−21,96 %
Current Ratio
3,86
Debt-to-Equity Ratio
15,36
Key figures (NOK)2022
Revenue51 000
Net Income−56 000
Total Assets4 220 000
Total Equity255 000
Income (NOK)2022
Revenue51 000
Expenditure52 000
Operating Profit−2 000
Financial Income0
Financial Costs54 000
Financial Balance−54 000
Earnings Before Tax−56 000
Tax0
Net Income−56 000
Balance (NOK)2022
Total Fixed Assets4 031 000
Total Current Assets189 000
Total Assets4 220 000
Total Retained Equity185 000
Total Equity255 000
Total Long-Term Debt3 916 000
Total Current Debt49 000
Total Equity and Debt4 220 000
Cash flow (NOK)2022
Sales Income0
Other Income51 000
Revenue51 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure52 000
Operating Profit−2 000
Financial Income0
Financial Costs54 000
Financial Balance−54 000
Dividends0
Net Income−56 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate4 009 000
Machinery and Plant Facilities0
Fixtures21 000
Total Tangible Assets4 031 000
Total Fiancial Fixed Assets0
Total Fixed Assets4 031 000
Stock0
Total Investments0
Cash, Bank59 000
Total Current Assets189 000
Total Assets4 220 000
Total Equity255 000
Short-Term Group Debt0
Total Long-Term Debt3 916 000
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt49 000
Total Current Debt49 000
Total Equity and Debt4 220 000
Financial indicators2022
Return on Equity−21,96 %
Debt-to-Equity Ratio15,36
Operating Profit Margin−3,92 %
Current Ratio3,86
Quick Ratio3,86
Equity Ratio0,06
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English